![Eric Schettini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Schettini
Directeur Général chez
TAFALGIE THERAPEUTICS
Profil
Eric Schettini is the founder of Tafalgie Therapeutics SA, founded in 2020, holding the title of President-Executive Board & CEO.
Mr. Schettini currently holds the position of Chairman at Tiempo SAS and serves on the Board of ACG Management SAS.
Postes actifs de Eric Schettini
| Sociétés | Poste | Début |
|---|---|---|
Tiempo SAS
 Tiempo SAS SemiconductorsElectronic Technology Designs and develops microelectronic security IP blocks & secure embedded software for securing connected objects | Président | - |
TAFALGIE THERAPEUTICS
 TAFALGIE THERAPEUTICS Miscellaneous Commercial ServicesCommercial Services Operates as a CNRS and AMU spin-off company engaged in biopharmaceutical research | Directeur Général | 01/01/2020 |
ACG Management SAS
 ACG Management SAS Investment ManagersFinance ACG Management invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for growth and buyout transactions with an average investment size of EUR 4.5 million and also acquires minority stakes in the companies. | Private Equity Investor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ACG Management SAS
ACG Management SAS Investment ManagersFinance ACG Management invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for growth and buyout transactions with an average investment size of EUR 4.5 million and also acquires minority stakes in the companies. | Finance |
Tiempo SAS
Tiempo SAS SemiconductorsElectronic Technology Designs and develops microelectronic security IP blocks & secure embedded software for securing connected objects | Electronic Technology |
TAFALGIE THERAPEUTICS
TAFALGIE THERAPEUTICS Miscellaneous Commercial ServicesCommercial Services Operates as a CNRS and AMU spin-off company engaged in biopharmaceutical research | Commercial Services |
